Sardinian Heal Italia Precision Medicine Center – Cagliari

Strategic hub for the integration of research, clinical practice and innovation in Precision Medicine

Director

Prof.ssa Sabrina Giglio

Director of the HEAL ITALIA Center for Precision Medicine, Cagliari Co-Founder, Officine

Coordinators

Prof. Andrea Perra

Full Professor of General Pathology, UniCA – Director of the HEAL ITALIA Center for Precision Medicine, Cagliari Co-Founder, Officine

Informations

CeSAR (Centro Servizi di Ateneo per la Ricerca) dell'Università degli Studi di Cagliari.
Cittadella Universitaria - Blocco A
S. P. Monserrato - Sestu Km 0.700 09042 Monserrato CA

direttore.cesar@unica.it

+39 070 675 6675

The Precision Medicine Center of Sardinia operates under agreement with CeSAR (Centro Servizi di Ateneo per la Ricerca) and is under the patronage of the University of Cagliari. Coordinated by Prof. Andrea Perra, scientific reference of the Programme, and directed by Prof.ssa Sabrina Giglio, it represents a strategic hub of the HEAL Italia network for the integration of research, clinical practice and innovation.

The Center focuses on hereditary and acquired genetic conditions and complex diseases with proliferative, degenerative and inflammatory bases, developing integrated services in advanced diagnostics and translational research.

The Sardinian HEAL Italia Precision Medicine Center has highly specialised expertise and cutting-edge technologies that enable the complete analysis of genomes, gene transcription and protein expression. Its distinctive feature is the ability to perform single-cell multi-omic analyses, providing an extremely detailed molecular characterisation of the pathological cellular component and its microenvironment.

This integrated approach accelerates the transition from scientific discovery to clinical applicability, enabling earlier identification of research findings that can genuinely impact patient care and prognosis.

The Center positions itself as the driver of a scalable and replicable model of Precision Medicine, oriented towards scientific and technological innovation, patient-centredness, responsiveness to the specific needs of local communities and the promotion of health.

Services

Identification of Diagnostic and Therapeutic Markers

Use of the most advanced sequencing and functional omic technologies to identify diagnostic, prognostic and therapy-response disease markers, including novel therapeutic targets.

Single-Cell Omic and Multi-Omic Technologies

Advanced analyses enabling detailed molecular characterisation of the pathological cellular component and its microenvironment through single-cell multi-omic systems.

Tissue Biobank and Cell Lines

Expansion of the tissue biobank and cell lines to support translational research and validation studies.

Functional Validation of Genomic Results

Functional validation of genomic results in synergy with the HEAL Italia Core Facility, to accelerate the transfer from research to clinical practice.